NWAM LLC’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.41M Buy
16,273
+374
+2% +$35.8K 0.08% 231
2025
Q4
$1.6M Buy
15,899
+2,395
+18% +$233K 0.09% 203
2025
Q3
$1.29M Buy
13,504
+3,612
+37% +$332K 0.07% 245
2025
Q2
$891K Buy
+9,892
New +$839K 0.05% 286
2025
Q1
Sell
-4,031
Closed -$322K 565
2024
Q4
$322K Sell
4,031
-531
-12% -$46K 0.02% 468
2024
Q3
$411K Sell
4,562
-281
-6% -$23.6K 0.03% 422
2024
Q2
$381K Buy
4,843
+351
+8% +$28.8K 0.11% 96
2024
Q1
$371K Buy
4,492
+141
+3% +$12K 0.03% 393
2023
Q4
$358K Buy
4,351
+291
+7% +$22.2K 0.03% 395
2023
Q3
$318K Sell
4,060
-658
-14% -$55.1K 0.03% 373
2023
Q2
$416K Buy
4,718
+525
+13% +$45.2K 0.03% 363
2023
Q1
$338K Sell
4,193
-1,102
-21% -$89.8K 0.03% 340
2022
Q4
$412K Buy
5,295
+486
+10% +$39.4K 0.04% 345
2022
Q3
$388K Sell
4,809
-1,746
-27% -$157K 0.04% 344
2022
Q2
$592K Sell
6,555
-754
-10% -$76.4K 0.05% 273
2022
Q1
$811K Buy
7,309
+2,775
+61% +$293K 0.06% 254
2021
Q4
$469K Buy
4,534
+1,269
+39% +$147K 0.04% 339
2021
Q3
$409K Sell
3,265
-160
-5% -$20.7K 0.04% 353
2021
Q2
$425K Sell
3,425
-1,187
-26% -$149K 0.04% 331
2021
Q1
$545K Buy
4,612
+771
+20% +$90.4K 0.05% 290
2020
Q4
$450K Buy
+3,841
New +$423K 0.05% 284
2020
Q3
Sell
-3,969
Closed -$364K 354
2020
Q2
$364K Buy
3,969
+543
+16% +$52.1K 0.05% 294
2020
Q1
$309 Buy
3,426
+447
+15% +$47.6K 0.01% 297
2019
Q4
$338K Sell
2,979
-112
-4% -$12.3K 0.06% 279
2019
Q3
$336K Sell
3,091
-86
-3% -$8.97K 0.06% 263
2019
Q2
$309K Sell
3,177
-155
-5% -$14.2K 0.06% 268
2019
Q1
$304K Sell
3,332
-175
-5% -$15.7K 0.07% 267
2018
Q4
$319K Buy
3,507
+62
+2% +$5.79K 0.08% 232
2018
Q3
$339K Buy
3,445
+772
+29% +$71.4K 0.08% 240
2018
Q2
$229K Sell
2,673
-97
-4% -$8.1K 0.05% 295
2018
Q1
$222K Buy
2,770
+203
+8% +$16.7K 0.06% 291
2017
Q4
$207K Sell
2,567
-858
-25% -$68.7K 0.05% 295
2017
Q3
$266K Buy
3,425
+397
+13% +$33K 0.07% 250
2017
Q2
$269K Sell
3,028
-1,051
-26% -$88.6K 0.05% 244
2017
Q1
$329K Buy
4,079
+1,109
+37% +$86.6K 0.1% 204
2016
Q4
$212K Sell
2,970
-214
-7% -$16.8K 0.07% 253
2016
Q3
$275K Buy
+3,184
New +$277K 0.02% 206
2016
Q2
Sell
-3,570
Closed -$268K 258
2016
Q1
$268K Sell
3,570
-489
-12% -$36.8K 0.11% 187
2015
Q4
$312K Buy
+4,059
New +$306K 0.13% 163
2015
Q2
Sell
-3,357
Closed -$262K 264
2015
Q1
$262K Buy
3,357
+87
+3% +$6.59K 0.11% 183
2014
Q4
$236K Sell
3,270
-203
-6% -$14.1K 0.1% 191
2014
Q3
$215K Sell
3,473
-1,189
-26% -$75.6K 0.08% 254
2014
Q2
$297K Buy
4,662
+203
+5% +$12.3K 0.09% 207
2014
Q1
$274K Buy
+4,459
New +$260K 0.09% 191

Other funds holding MDT

NWAM LLC's MDT Position: Q1 2026 in Review

NWAM LLC increased its Medtronic (MDT) stake by 2.4% in Q1 2026, buying an estimated $35.8K and bringing the position to 16,273 shares worth $1.41M. The position accounts for 0.08% of the portfolio, ranked #231.

NWAM LLC first reported a position in MDT in Q1 2014 and has held it in 44 quarters since. The position peaked at $1.6M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • NWAM LLC held 16,273 shares of Medtronic worth $1.41M as of Q1 2026.
  • NWAM LLC bought 374 Medtronic shares in Q1 2026, an estimated $35.8K.
  • Medtronic made up 0.08% of NWAM LLC's portfolio in Q1 2026, its #231 holding.
  • NWAM LLC first reported a position in Medtronic in Q1 2014 and has held it in 44 quarters since.
  • NWAM LLC's Medtronic position peaked at $1.6M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on NWAM LLC's 13F filing for Q1 2026, filed 4 May 2026.